{"id":2708,"date":"2024-01-05T22:40:05","date_gmt":"2024-01-05T22:40:05","guid":{"rendered":"https:\/\/coreplus.wpengine.com\/posts\/arteraai-anuncia-acuerdo-de-investigacion-con-coreplus\/"},"modified":"2024-03-13T14:42:05","modified_gmt":"2024-03-13T14:42:05","slug":"arteraai-anuncia-acuerdo-de-investigacion-con-coreplus","status":"publish","type":"post","link":"https:\/\/corepluspr.com\/es\/posts\/arteraai-anuncia-acuerdo-de-investigacion-con-coreplus\/","title":{"rendered":"ArteraAI anuncia acuerdo de investigaci\u00f3n con CorePlus"},"content":{"rendered":"\n

ArteraAI, un desarrollador de pruebas de c\u00e1ncer basadas en inteligencia artificial, se ha asociado con CorePlus, un laboratorio de patolog\u00eda certificado por CLIA en Puerto Rico. La colaboraci\u00f3n se centra en validar la prueba de pr\u00f3stata ArteraAI dentro de la poblaci\u00f3n hispana.<\/p>\n\n

Estamos emocionados de colaborar con ArteraAI para promover el avance y la reducci\u00f3n de las desigualdades en el diagn\u00f3stico y tratamiento del c\u00e1ncer de pr\u00f3stata\u201d, dijo Mariano de Socarraz, director ejecutivo de CorePlus.<\/p>\n\n

Haga clic aqu\u00ed para leer el art\u00edculo completo en Businesswire.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

ArteraAI, un desarrollador de pruebas de c\u00e1ncer basadas en inteligencia artificial, se ha asociado con CorePlus, un laboratorio de patolog\u00eda certificado por CLIA en Puerto Rico.<\/p>\n","protected":false},"author":1,"featured_media":2685,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[57],"tags":[47],"class_list":["post-2708","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-publicaciones","tag-featured-es"],"acf":[],"yoast_head":"\nArteraAI anuncia acuerdo de investigaci\u00f3n con CorePlus - CorePlus<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/corepluspr.com\/posts\/arteraai-announces-research-agreement-with-coreplus\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ArteraAI anuncia acuerdo de investigaci\u00f3n con CorePlus - CorePlus\" \/>\n<meta property=\"og:description\" content=\"ArteraAI, un desarrollador de pruebas de c\u00e1ncer basadas en inteligencia artificial, se ha asociado con CorePlus, un laboratorio de patolog\u00eda certificado por CLIA en Puerto Rico.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/corepluspr.com\/posts\/arteraai-announces-research-agreement-with-coreplus\/\" \/>\n<meta property=\"og:site_name\" content=\"CorePlus\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/corepluspr\" \/>\n<meta property=\"article:published_time\" content=\"2024-01-05T22:40:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-03-13T14:42:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/corepluspr.com\/wp-content\/uploads\/2024\/01\/blog-post_artera.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"980\" \/>\n\t<meta property=\"og:image:height\" content=\"735\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"gara12\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@corepluspr\" \/>\n<meta name=\"twitter:site\" content=\"@corepluspr\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"gara12\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/corepluspr.com\/posts\/arteraai-announces-research-agreement-with-coreplus\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/corepluspr.com\/posts\/arteraai-announces-research-agreement-with-coreplus\/\"},\"author\":{\"name\":\"gara12\",\"@id\":\"https:\/\/corepluspr.com\/#\/schema\/person\/7d3f1349f693766a1f8668fd1769cf4e\"},\"headline\":\"ArteraAI anuncia acuerdo de investigaci\u00f3n con CorePlus\",\"datePublished\":\"2024-01-05T22:40:05+00:00\",\"dateModified\":\"2024-03-13T14:42:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/corepluspr.com\/posts\/arteraai-announces-research-agreement-with-coreplus\/\"},\"wordCount\":104,\"publisher\":{\"@id\":\"https:\/\/corepluspr.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/corepluspr.com\/posts\/arteraai-announces-research-agreement-with-coreplus\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/corepluspr.com\/wp-content\/uploads\/2024\/01\/blog-post_artera.jpg\",\"keywords\":[\"featured\"],\"articleSection\":[\"Publicaciones\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/corepluspr.com\/posts\/arteraai-announces-research-agreement-with-coreplus\/\",\"url\":\"https:\/\/corepluspr.com\/posts\/arteraai-announces-research-agreement-with-coreplus\/\",\"name\":\"ArteraAI anuncia acuerdo de investigaci\u00f3n con CorePlus - CorePlus\",\"isPartOf\":{\"@id\":\"https:\/\/corepluspr.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/corepluspr.com\/posts\/arteraai-announces-research-agreement-with-coreplus\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/corepluspr.com\/posts\/arteraai-announces-research-agreement-with-coreplus\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/corepluspr.com\/wp-content\/uploads\/2024\/01\/blog-post_artera.jpg\",\"datePublished\":\"2024-01-05T22:40:05+00:00\",\"dateModified\":\"2024-03-13T14:42:05+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/corepluspr.com\/posts\/arteraai-announces-research-agreement-with-coreplus\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/corepluspr.com\/posts\/arteraai-announces-research-agreement-with-coreplus\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/corepluspr.com\/posts\/arteraai-announces-research-agreement-with-coreplus\/#primaryimage\",\"url\":\"https:\/\/corepluspr.com\/wp-content\/uploads\/2024\/01\/blog-post_artera.jpg\",\"contentUrl\":\"https:\/\/corepluspr.com\/wp-content\/uploads\/2024\/01\/blog-post_artera.jpg\",\"width\":980,\"height\":735,\"caption\":\"Logo de Artera\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/corepluspr.com\/posts\/arteraai-announces-research-agreement-with-coreplus\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/corepluspr.com\/es\/inicio\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ArteraAI anuncia acuerdo de investigaci\u00f3n con CorePlus\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/corepluspr.com\/#website\",\"url\":\"https:\/\/corepluspr.com\/\",\"name\":\"CorePlus\",\"description\":\"A Global Leader in Precision Pathology and Laboratory Testing\",\"publisher\":{\"@id\":\"https:\/\/corepluspr.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/corepluspr.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/corepluspr.com\/#organization\",\"name\":\"CorePlus\",\"url\":\"https:\/\/corepluspr.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/corepluspr.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/corepluspr.com\/wp-content\/uploads\/2023\/08\/CP_logo-9.png\",\"contentUrl\":\"https:\/\/corepluspr.com\/wp-content\/uploads\/2023\/08\/CP_logo-9.png\",\"width\":600,\"height\":600,\"caption\":\"CorePlus\"},\"image\":{\"@id\":\"https:\/\/corepluspr.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/corepluspr\",\"https:\/\/x.com\/corepluspr\",\"https:\/\/www.instagram.com\/corepluspr\/\",\"https:\/\/www.youtube.com\/@corepluspr\",\"https:\/\/www.linkedin.com\/company\/corepluspr\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/corepluspr.com\/#\/schema\/person\/7d3f1349f693766a1f8668fd1769cf4e\",\"name\":\"gara12\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/corepluspr.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bdba659dc1da3abff3010f8896bda5cae3ac7987bcdcf33d51c96240435c36da?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bdba659dc1da3abff3010f8896bda5cae3ac7987bcdcf33d51c96240435c36da?s=96&d=mm&r=g\",\"caption\":\"gara12\"},\"sameAs\":[\"https:\/\/coreplus.wpengine.com\"],\"url\":\"https:\/\/corepluspr.com\/es\/posts\/author\/gara12\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ArteraAI anuncia acuerdo de investigaci\u00f3n con CorePlus - CorePlus","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/corepluspr.com\/posts\/arteraai-announces-research-agreement-with-coreplus\/","og_locale":"es_ES","og_type":"article","og_title":"ArteraAI anuncia acuerdo de investigaci\u00f3n con CorePlus - CorePlus","og_description":"ArteraAI, un desarrollador de pruebas de c\u00e1ncer basadas en inteligencia artificial, se ha asociado con CorePlus, un laboratorio de patolog\u00eda certificado por CLIA en Puerto Rico.","og_url":"https:\/\/corepluspr.com\/posts\/arteraai-announces-research-agreement-with-coreplus\/","og_site_name":"CorePlus","article_publisher":"https:\/\/www.facebook.com\/corepluspr","article_published_time":"2024-01-05T22:40:05+00:00","article_modified_time":"2024-03-13T14:42:05+00:00","og_image":[{"width":980,"height":735,"url":"https:\/\/corepluspr.com\/wp-content\/uploads\/2024\/01\/blog-post_artera.jpg","type":"image\/jpeg"}],"author":"gara12","twitter_card":"summary_large_image","twitter_creator":"@corepluspr","twitter_site":"@corepluspr","twitter_misc":{"Escrito por":"gara12"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/corepluspr.com\/posts\/arteraai-announces-research-agreement-with-coreplus\/#article","isPartOf":{"@id":"https:\/\/corepluspr.com\/posts\/arteraai-announces-research-agreement-with-coreplus\/"},"author":{"name":"gara12","@id":"https:\/\/corepluspr.com\/#\/schema\/person\/7d3f1349f693766a1f8668fd1769cf4e"},"headline":"ArteraAI anuncia acuerdo de investigaci\u00f3n con CorePlus","datePublished":"2024-01-05T22:40:05+00:00","dateModified":"2024-03-13T14:42:05+00:00","mainEntityOfPage":{"@id":"https:\/\/corepluspr.com\/posts\/arteraai-announces-research-agreement-with-coreplus\/"},"wordCount":104,"publisher":{"@id":"https:\/\/corepluspr.com\/#organization"},"image":{"@id":"https:\/\/corepluspr.com\/posts\/arteraai-announces-research-agreement-with-coreplus\/#primaryimage"},"thumbnailUrl":"https:\/\/corepluspr.com\/wp-content\/uploads\/2024\/01\/blog-post_artera.jpg","keywords":["featured"],"articleSection":["Publicaciones"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/corepluspr.com\/posts\/arteraai-announces-research-agreement-with-coreplus\/","url":"https:\/\/corepluspr.com\/posts\/arteraai-announces-research-agreement-with-coreplus\/","name":"ArteraAI anuncia acuerdo de investigaci\u00f3n con CorePlus - CorePlus","isPartOf":{"@id":"https:\/\/corepluspr.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/corepluspr.com\/posts\/arteraai-announces-research-agreement-with-coreplus\/#primaryimage"},"image":{"@id":"https:\/\/corepluspr.com\/posts\/arteraai-announces-research-agreement-with-coreplus\/#primaryimage"},"thumbnailUrl":"https:\/\/corepluspr.com\/wp-content\/uploads\/2024\/01\/blog-post_artera.jpg","datePublished":"2024-01-05T22:40:05+00:00","dateModified":"2024-03-13T14:42:05+00:00","breadcrumb":{"@id":"https:\/\/corepluspr.com\/posts\/arteraai-announces-research-agreement-with-coreplus\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/corepluspr.com\/posts\/arteraai-announces-research-agreement-with-coreplus\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/corepluspr.com\/posts\/arteraai-announces-research-agreement-with-coreplus\/#primaryimage","url":"https:\/\/corepluspr.com\/wp-content\/uploads\/2024\/01\/blog-post_artera.jpg","contentUrl":"https:\/\/corepluspr.com\/wp-content\/uploads\/2024\/01\/blog-post_artera.jpg","width":980,"height":735,"caption":"Logo de Artera"},{"@type":"BreadcrumbList","@id":"https:\/\/corepluspr.com\/posts\/arteraai-announces-research-agreement-with-coreplus\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/corepluspr.com\/es\/inicio\/"},{"@type":"ListItem","position":2,"name":"ArteraAI anuncia acuerdo de investigaci\u00f3n con CorePlus"}]},{"@type":"WebSite","@id":"https:\/\/corepluspr.com\/#website","url":"https:\/\/corepluspr.com\/","name":"CorePlus","description":"A Global Leader in Precision Pathology and Laboratory Testing","publisher":{"@id":"https:\/\/corepluspr.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/corepluspr.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/corepluspr.com\/#organization","name":"CorePlus","url":"https:\/\/corepluspr.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/corepluspr.com\/#\/schema\/logo\/image\/","url":"https:\/\/corepluspr.com\/wp-content\/uploads\/2023\/08\/CP_logo-9.png","contentUrl":"https:\/\/corepluspr.com\/wp-content\/uploads\/2023\/08\/CP_logo-9.png","width":600,"height":600,"caption":"CorePlus"},"image":{"@id":"https:\/\/corepluspr.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/corepluspr","https:\/\/x.com\/corepluspr","https:\/\/www.instagram.com\/corepluspr\/","https:\/\/www.youtube.com\/@corepluspr","https:\/\/www.linkedin.com\/company\/corepluspr"]},{"@type":"Person","@id":"https:\/\/corepluspr.com\/#\/schema\/person\/7d3f1349f693766a1f8668fd1769cf4e","name":"gara12","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/corepluspr.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bdba659dc1da3abff3010f8896bda5cae3ac7987bcdcf33d51c96240435c36da?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bdba659dc1da3abff3010f8896bda5cae3ac7987bcdcf33d51c96240435c36da?s=96&d=mm&r=g","caption":"gara12"},"sameAs":["https:\/\/coreplus.wpengine.com"],"url":"https:\/\/corepluspr.com\/es\/posts\/author\/gara12\/"}]}},"_links":{"self":[{"href":"https:\/\/corepluspr.com\/es\/wp-json\/wp\/v2\/posts\/2708","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/corepluspr.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/corepluspr.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/corepluspr.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/corepluspr.com\/es\/wp-json\/wp\/v2\/comments?post=2708"}],"version-history":[{"count":0,"href":"https:\/\/corepluspr.com\/es\/wp-json\/wp\/v2\/posts\/2708\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/corepluspr.com\/es\/wp-json\/wp\/v2\/media\/2685"}],"wp:attachment":[{"href":"https:\/\/corepluspr.com\/es\/wp-json\/wp\/v2\/media?parent=2708"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/corepluspr.com\/es\/wp-json\/wp\/v2\/categories?post=2708"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/corepluspr.com\/es\/wp-json\/wp\/v2\/tags?post=2708"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}